Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 32 (1) , 78-88
- https://doi.org/10.1016/0190-9622(95)90189-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis: An assessment of clinical significance when viewed as a risk factor for cardiovascular diseaseJournal of the American Academy of Dermatology, 1992
- Morphologic renal changes during cyclosporine treatment of psoriasis: Studies on pretreatment and posttreatment kidney biopsy specimensJournal of the American Academy of Dermatology, 1992
- Alterations in renal function in psoriasis patients treated with cyclosporin, 5 mg/kg/dayJournal of the American Academy of Dermatology, 1992
- Hypertriglyceridemia in patients with psoriasis treated with cyclosporineJournal of the American Academy of Dermatology, 1991
- Laboratory monitoring of cyclosporine levels: Guidelines for the dermatologistJournal of the American Academy of Dermatology, 1990
- Systemic and local administration of cyclosporine in the treatment of psoriasisJournal of the American Academy of Dermatology, 1990
- Renal effects of cyclosporineJournal of the American Academy of Dermatology, 1990
- Cyclosporine therapy for psoriasis: Serum creatinine measurements are an unreliable predictor of decreased renal functionJournal of the American Academy of Dermatology, 1989
- Acitretin versus etretinate in psoriasisJournal of the American Academy of Dermatology, 1988
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987